Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial.

Dillon MT, Patin EC, Mohammed K, Guevara J, Smith SA, Dean E, Soliman H, Nenclares P, Ryugenji M, Northcote D, Shah N, Grove L, Lord CJ, Pettit S, Tall M, Swales KE, Banerji U, Melcher AA, Saunders M, Forster MD, Harrington KJ

Open source

DOI: 10.1038/s41467-025-62249-0
Published: 2025 Aug 1
Container: Nature communications
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-025-62249-0,
  title = {Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial.},
  author = {Dillon MT and Patin EC and Mohammed K and Guevara J and Smith SA and Dean E and Soliman H and Nenclares P and Ryugenji M and Northcote D and Shah N and Grove L and Lord CJ and Pettit S and Tall M and Swales KE and Banerji U and Melcher AA and Saunders M and Forster MD and Harrington KJ},
  year = {2025},
  journal = {Nature communications},
  doi = {10.1038/s41467-025-62249-0},
  url = {https://doi.org/10.1038/s41467-025-62249-0}
}

RIS

TY  - JOUR
TI  - Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial.
AU  - Dillon MT
AU  - Patin EC
AU  - Mohammed K
AU  - Guevara J
AU  - Smith SA
AU  - Dean E
AU  - Soliman H
AU  - Nenclares P
AU  - Ryugenji M
AU  - Northcote D
AU  - Shah N
AU  - Grove L
AU  - Lord CJ
AU  - Pettit S
AU  - Tall M
AU  - Swales KE
AU  - Banerji U
AU  - Melcher AA
AU  - Saunders M
AU  - Forster MD
AU  - Harrington KJ
PY  - 2025
JO  - Nature communications
DO  - 10.1038/s41467-025-62249-0
UR  - https://doi.org/10.1038/s41467-025-62249-0
ER  -

APA

MT, D., EC, P., K, M., J, G., SA, S., E, D., H, S., P, N., M, R., D, N., N, S., L, G., CJ, L., S, P., M, T., KE, S., U, B., AA, M., M, S., MD, F., & KJ, H. (2025). Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial.. Nature communications. https://doi.org/10.1038/s41467-025-62249-0

Source records

pubmed · retrieved 2026-09-26T08:16:46.843Z
europe-pmc · retrieved 2026-09-26T08:16:46.871Z
doaj · retrieved 2026-09-26T08:16:46.840Z